Results 111 to 120 of about 37,220 (200)

Langerhans cell histiocytosis manifesting at birth: a neonatal case with BRAF V600E mutation. [PDF]

Diagn Pathol
Tang W, Wang P.
europepmc   +1 more source

Interpreting Deep Learning-Based Prediction of the BRAF V600E Mutation Using Diagnostic Whole Slide Images in Skin Cutaneous Melanoma. [PDF]

Am J Pathol
Rao VR, Nguyen V, Phung TL, Sukhadia SS.
europepmc   +1 more source

Non‐V600E BRAF mutation in hairy cell leukemia variant

eJHaem, 2023
Anjanaa Vijayanarayanan, Sa A. Wang, Sofia Garces, Karan Saluja, L. Jeffrey Medeiros, Beenu Thakral   +5 more
openaire   +3 more sources

Prevalence and prognostic impact of BRAF V600E mutation and CDKN2A deletion in pediatric high-grade glioma. [PDF]

Front Oncol
Karim S, Mosaab A, Taha H, Naguib I, Refaat A, Maher E, Zaghloul MS, El-Beltagy M, Hafez H, Kamal M, Salem S, Kieran MW, El-Hemaly A, El-Haddad A.   +13 more
europepmc   +1 more source

BRAF V600E Mutation in Ganglioglioma: Impact on Epileptogenicity and Implications for Surgical Strategy. [PDF]

Eur J Neurol
Tomschik M, Horner E, Lang A, Mayer F, Czech T, Kasprian G, Pataraia E, Azizi AA, Feucht M, Rössler K, Haberler C, Dorfer C.   +11 more
europepmc   +1 more source

A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer [PDF]

, 2019
Baranski, Thomas, DeWees, Todd, Grigsby, Perry, Henke, Lauren, Lin, Alexander J, Markovina, Stephanie, Pfeifer, John, Samson, Pamela, Schwarz, Julie   +8 more
core   +1 more source

Successful treatment of osimertinib-resistant EGFR-mutant NSCLC with acquired BRAF V600E mutation using triple combination therapy: a case report with pathological confirmation. [PDF]

World J Surg Oncol
Lin M, Chen X, Lin F, Yang Y.
europepmc   +1 more source

Rare MSI-H hepatoid adenocarcinoma of the colon with BRAF V600E mutation achieving long-term disease-free survival after adjuvant envafolimab: a case report. [PDF]

Front Immunol
Fan S, Meng Q, Zhao Z, Niu W.
europepmc   +1 more source

Response to dabrafenib and trametinib combined with pembrolizumab in an elderly patient with lung adenocarcinoma of unknown primary harboring BRAF V600E mutation and high PD-L1 expression: a case report. [PDF]

Front Immunol
Li N, Hu J, Bao G, Cai Z.
europepmc   +1 more source

Deep learning model based on ultrasound images predicts BRAF V600E mutation in papillary thyroid carcinoma. [PDF]

iScience
Yu Y, Zhao C, Guo R, Zhang Y, Li X, Liu N, Lu Y, Han X, Tang X, Mao R, Peng C, Yu J, Zhou J.   +12 more
europepmc   +1 more source